Филтриране по Last updated date SelectСледПредиFrom - To Дата Крайна дата This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Резултати (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Regulators in EU, Japan and US take steps to facilitate development of new antibiotics 12 June 2017NewsCorporate Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 June 2017 9 June 2017NewsHumanPharmacovigilance PRAC concludes there is no evidence of a change in known risk of neutropenic enterocolitis with docetaxel 9 June 2017Press releaseHumanPharmacovigilance Workshop: addressing unmet needs of children with pulmonary arterial hypertension 6 June 2017NewsCorporatePaediatrics European Medicines Agency closed 5 June 2017 1 June 2017NewsCorporateMedicines New action plan to support SMEs as drivers of pharmaceutical innovation 31 May 2017NewsCorporateSME Regulatory guidance for industry to prepare for the UK's withdrawal from the EU 31 May 2017NewsCorporateBrexit East African Community looks to EMA as model for future regional agency 23 May 2017NewsCorporate European Medicines Agency closed 25-26 May 2017 23 May 2017NewsCorporateMedicines Green light given for new EudraVigilance system for collection and monitoring of suspected adverse reactions 22 May 2017NewsCorporate 1 … 135 136 137 138 139 Page 139 of 380 140 141 142 143 … 380
Regulators in EU, Japan and US take steps to facilitate development of new antibiotics 12 June 2017NewsCorporate
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 June 2017 9 June 2017NewsHumanPharmacovigilance
PRAC concludes there is no evidence of a change in known risk of neutropenic enterocolitis with docetaxel 9 June 2017Press releaseHumanPharmacovigilance
Workshop: addressing unmet needs of children with pulmonary arterial hypertension 6 June 2017NewsCorporatePaediatrics
Regulatory guidance for industry to prepare for the UK's withdrawal from the EU 31 May 2017NewsCorporateBrexit
Green light given for new EudraVigilance system for collection and monitoring of suspected adverse reactions 22 May 2017NewsCorporate